Short-Term Single-Blind Fluvoxamine Treatment of Pathological Gambling

Abstract
The authors' goal was to assess the efficacy and tolerability of the selective serotonin reuptake inhibitor fluvoxamine in the treatment of pathological gambling.

This publication has 0 references indexed in Scilit: